[Asia Economy Reporter Yoo Hyun-seok] Wooridle Hubrain announced on the 24th that its investment returns reached 26.9 billion KRW, which amounts to about 20% of its market capitalization.
Wooridle Hubrain's evaluation gains from the 30 billion KRW convertible bonds (CB) of Aprogen MED, acquired in October last year, reached 3 billion KRW, about 10% of the investment amount. Additionally, the evaluation gains from the 6.5 billion KRW CB of ITEK, acquired in November of the same year, stood at approximately 5.3 billion KRW. Along with this, the evaluation gains from the bonds with warrants (BW) of Syswork, which acquired the diagnostic kit company BBB, exceeded 100% of the investment scale.
In particular, Wooridle Hubrain, which acquired 10 billion KRW worth of CB from Bucket Studio at the end of last year, realized evaluation gains of 15.9 billion KRW, nearly 150% of the investment amount.
Meanwhile, Wooridle Hubrain is now focusing intensively on strengthening its medical business. At the same time, through its affiliate investment associations, it is forming new technology and value investment funds, pursuing both stability and profitability in the mergers and acquisitions (M&A) market, thereby maximizing the discovery of promising investment destinations and investment efficiency.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![From Bar Hostess to Organ Seller to High Society... The Grotesque Con of a "Human Counterfeit" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
